AN2 Therapeutics, Inc. (ANTX)

Exchange NASDAQ
8.75


Currency in USD (Disclaimer)
Volume:
Day's Range:

ANTX Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-21 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 3,748,389.0 P-Purchase A 302.0 7.99 2,412.98
2022-06-14 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 3,748,087.0 P-Purchase A 61,424.0 7.97 489,401.86
2022-06-13 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 3,686,663.0 P-Purchase A 20,000.0 7.90 158,000.00
2022-06-06 Aziz Kabeer director, 10 percent owner 413,156.0 J-Other A 26,511.0 15.00 397,665.00
2022-06-06 Aziz Kabeer director, 10 percent owner 2,184,224.0 J-Other D 26,511.0 15.00 397,665.00
2022-06-06 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 413,156.0 J-Other A 26,511.0 15.00 397,665.00
2022-06-06 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 2,184,224.0 J-Other D 26,511.0 15.00 397,665.00
2022-05-12 Chanda Sanjay officer: Chief Development Officer 66,000.0 A-Award A 66,000.0 17.28 1,140,480.00
2022-05-12 Readnour Robin Shane director 20,724.0 A-Award A 20,724.0 17.28 358,110.72
2022-05-12 FitzPatrick Margaret M director 10,362.0 A-Award A 10,362.0 17.28 179,055.36
2022-05-12 Nazak Michael Adrian officer: Chief Accounting Officer 14,300.0 A-Award A 14,300.0 17.28 247,104.00
2022-05-12 Wong Stephanie director 10,362.0 A-Award A 10,362.0 17.28 179,055.36
2022-05-12 Martin Patricia A. director 10,362.0 A-Award A 10,362.0 17.28 179,055.36
2022-05-12 Eckburg Paul officer: Chief Medical Officer 66,000.0 A-Award A 66,000.0 17.28 1,140,480.00
2022-05-12 Spigelman Melvin K director 10,362.0 A-Award A 10,362.0 17.28 179,055.36
2022-05-12 Aziz Kabeer director 20,724.0 A-Award A 20,724.0 17.28 358,110.72
2022-05-12 Day Lucy officer: Chief Financial Officer 66,000.0 A-Award A 66,000.0 17.28 1,140,480.00
2022-05-12 Krause Kevin Michael officer: Chief Strategy Officer 66,000.0 A-Award A 66,000.0 17.28 1,140,480.00
2022-05-12 Easom Eric director, officer: Chief Executive Officer 225,000.0 A-Award A 225,000.0 17.28 3,888,000.00
2022-05-12 Marks Gilbert Lynn director 10,362.0 A-Award A 10,362.0 17.28 179,055.36
2022-05-12 Zakrzewski Joseph S director 10,362.0 A-Award A 10,362.0 17.28 179,055.36
2022-05-05 FitzPatrick Margaret M director 11,463.0 A-Award A 11,463.0 18.24 209,085.12
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 0.0 C-Conversion D 74,230.0 0.00 0.00
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 0.0 C-Conversion D 74,230.0 0.00 0.00
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 2,210,735.0 P-Purchase A 166,666.0 15.00 2,499,990.00
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 386,645.0 C-Conversion A 74,230.0 0.00 0.00
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 2,044,069.0 C-Conversion A 392,433.0 0.00 0.00
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 312,415.0 C-Conversion A 312,415.0 0.00 0.00
2022-03-29 Adjuvant Global Health Technology Fund, L.P. 10 percent owner 1,651,636.0 C-Conversion A 1,651,636.0 0.00 0.00
2022-03-29 Aziz Kabeer director, 10 percent owner 0.0 C-Conversion D 74,230.0 0.00 0.00
2022-03-29 Aziz Kabeer director, 10 percent owner 0.0 C-Conversion D 74,230.0 0.00 0.00
2022-03-29 Aziz Kabeer director, 10 percent owner 2,210,735.0 P-Purchase A 166,666.0 15.00 2,499,990.00
2022-03-29 Aziz Kabeer director, 10 percent owner 386,645.0 C-Conversion A 74,230.0 0.00 0.00
2022-03-29 Aziz Kabeer director, 10 percent owner 2,044,069.0 C-Conversion A 392,433.0 0.00 0.00
2022-03-29 Aziz Kabeer director, 10 percent owner 312,415.0 C-Conversion A 312,415.0 0.00 0.00
2022-03-29 Aziz Kabeer director, 10 percent owner 1,651,636.0 C-Conversion A 1,651,636.0 0.00 0.00
2022-03-29 Easom Eric director, officer: Chief Executive Officer 0.0 C-Conversion D 4,907.0 0.00 0.00
2022-03-29 Easom Eric director, officer: Chief Executive Officer 4,907.0 C-Conversion A 4,907.0 0.00 0.00
2022-03-29 Readnour Robin Shane director 0.0 C-Conversion D 71,839.0 0.00 0.00
2022-03-29 Readnour Robin Shane director 0.0 C-Conversion D 71,839.0 0.00 0.00
2022-03-29 Readnour Robin Shane director 487,592.0 P-Purchase A 82,618.0 15.00 1,239,270.00
2022-03-29 Readnour Robin Shane director 417,363.0 P-Purchase A 70,716.0 15.00 1,060,740.00
2022-03-29 Readnour Robin Shane director 404,974.0 C-Conversion A 71,839.0 0.00 0.00
2022-03-29 Readnour Robin Shane director 346,647.0 C-Conversion A 61,491.0 0.00 0.00
2022-03-29 Readnour Robin Shane director 333,135.0 C-Conversion A 333,135.0 0.00 0.00
2022-03-29 Readnour Robin Shane director 285,156.0 C-Conversion A 285,156.0 0.00 0.00
2022-03-29 Zakrzewski Joseph S director 0.0 C-Conversion D 98,199.0 0.00 0.00
2022-03-29 Zakrzewski Joseph S director 98,199.0 C-Conversion A 98,199.0 0.00 0.00
2022-03-29 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 0.0 C-Conversion D 299,999.0 0.00 0.00
2022-03-29 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 415,612.0 P-Purchase A 115,613.0 15.00 1,734,195.00
2022-03-29 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 299,999.0 C-Conversion A 299,999.0 0.00 0.00
2022-03-29 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 3,251,051.0 P-Purchase A 1,551,053.0 15.00 23,265,795.00
2022-03-29 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 1,699,998.0 C-Conversion A 1,699,998.0 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.